NFE2L2 and hepatocellular carcinoma: High expression of p62 shortens the survival of patients with HCC,42, 45 and evidence indicates that p62 may contributed to the progression of HCC through the mammalian target of rapamycin complex 1 pathway46 and the nuclear factor erythroid 2 like 2 (NRF2)‐L‐Kelch Like ECH‐associated protein 1 pathway.47